Qilu Hospital of Shandong University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.qiluhospital.com
First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer
Phase 2
Active, not recruiting
- Conditions
- HER2-positive Gastric Cancer
- Interventions
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 55
- Registration Number
- NCT05586061
- Locations
- 🇨🇳
Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
🇨🇳Qilu Hospital of Shandong University, Jinan, Shandong, China
🇨🇳Shandong Provincial Hospital Affiliated to Shandong First Medical Universiry, Jinan, Shandong, China
Clinical Efficacy of High-flow Nasal Cannula Oxygen Therapy in Patients With Obstructive Sleep Apnea
Not Applicable
- Conditions
- Obstructive Sleep Apnea
- Interventions
- Device: high-flow nasal cannula oxygen therapy,Device: CPAP
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 194
- Registration Number
- NCT05549245
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics
Completed
- Conditions
- Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 666
- Registration Number
- NCT05550805
- Locations
- 🇨🇳
Yuguo Chen, Jinan, Shandong, China
Long-term Effect of High Flow Nasal Canula Therapy on Obstructive Sleep Apnea
Not Applicable
Recruiting
- Conditions
- High Flow Nasal CanulaObstructive Sleep ApneaContinuous Positive Airway Pressure Ventilation
- Interventions
- Device: CPAPDevice: high-flow nasal canula oxygen therapy
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 186
- Registration Number
- NCT05549310
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices
- Conditions
- Anticoagulants and Bleeding DisordersTissue AdhesionGastric Varices Bleeding
- Interventions
- Drug: Low molecular weight heparin
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2022-09-19
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 100
- Registration Number
- NCT05545475
- Locations
- 🇨🇳
Department of Gastroenterology,Qilu Hospital,Shandong University, Jinan, Shandong, China
Clinical Application of Wearable Magnet Tracking System for Capsule Endoscopes
Not Applicable
Recruiting
- Conditions
- Capsule Endoscopes
- Interventions
- Device: wearable magnet tracking system
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 10
- Registration Number
- NCT05546346
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Type 2 Diabetes Intervention by Gut Microbiota-directed Diet -a Open Labelled RCT
Not Applicable
Recruiting
- Conditions
- Type 2 Diabetes
- Interventions
- Dietary Supplement: Food
- First Posted Date
- 2022-09-15
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 200
- Registration Number
- NCT05541237
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Safety and Efficacy of Emergent TAVI in Patients With Severe AS
Not yet recruiting
- Conditions
- Transcatheter Aortic Valve ImplantationEmergenciesAortic Valve Stenosis
- First Posted Date
- 2022-09-06
- Last Posted Date
- 2022-09-06
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 10
- Registration Number
- NCT05528211
The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients
Phase 4
Active, not recruiting
- Conditions
- Ankylosing Spondylitis
- Interventions
- First Posted Date
- 2022-09-02
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 100
- Registration Number
- NCT05527444
- Locations
- 🇨🇳
Qilu Hospital, Jinan, Shandong, China
Efficacy and Safety of Pirfenidone in CTD-ILD
Phase 4
Recruiting
- Conditions
- PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
- Interventions
- Drug: glucocorticoid and immunosuppressant
- First Posted Date
- 2022-08-17
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 120
- Registration Number
- NCT05505409
- Locations
- 🇨🇳
Qilu Hospital, Jinan, Shandong, China
© Copyright 2025. All Rights Reserved by MedPath